Pretomanid for tuberculosis treatment: an update for clinical purposes

• Main Authors: Sara Occhineri (Author), Tommaso Matucci (Author), Laura Rindi (Author), Giusy Tiseo (Author), Marco Falcone (Author), Niccolò Riccardi (Author), Giorgio Besozzi (Author)
• Format: Book
• Published: Elsevier, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Coronavirus disease (COVID-19) pandemic determined a 10 years-set back in tuberculosis (TB) control programs. Recent advances in available therapies may help recover the time lost. While Linezolid (LZD) and Bedaquiline (BDQ), previously Group D second line drugs (SLDs) for TB, have been relocated to...